about
Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftmentThe Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivityCirculating MMP11 and specific antibody immune response in breast and prostate cancer patientsBlockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.Lung cancer stem cell lose their stemness default state after exposure to microgravity.Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancerActivation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells.EMT markers in lung adenocarcinoma pleural effusion spheroid cells.Neurotrophin system activation in pleural effusions.Metabolic features of cancer stem cells: the emerging role of lipid metabolism.WT1 CpG islands methylation in human lung cancer: a pilot study.Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanomaModified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic childrenB4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem CellsCytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions
P50
Q28742459-F7A4D10B-A751-4A15-900D-76A647947DC0Q36618973-5C457F56-D86E-43A0-88B7-C9078993BE54Q36634788-572885A2-94DD-4D0E-A2B1-2AA5F3DE6F7BQ37607101-E96B087E-2264-40DB-B2F8-CE33AB126929Q38629943-874CD56B-F75C-4B87-AF87-3B41A5CB1D65Q38849622-24A58652-8B72-457D-A719-51AF342DF344Q38860987-ACBC1713-E34E-4927-B448-AFE6F7415C29Q38951199-7F73B5ED-4C6E-4CD8-B9BD-4C4436D8E847Q39118597-595C60F0-98A1-40FC-BC3F-8C689C88AB71Q39119920-EE0A259A-BB5C-4F21-A013-E88FB05BF6B9Q41844678-839EE6FC-233D-46A5-B4DE-218B74CF7412Q46094278-53540A99-8966-4A5A-9A5E-570EE6CD0697Q48278925-1E3424C0-76FE-4F43-AF0C-4FC3ADEB9EB1Q52731934-1FA004FE-26ED-4D3C-8FAA-185D8EC9F544Q53265436-AB39754A-4266-4C8A-A3C7-7115E76AE104Q60044461-015E8CC5-4C12-44F1-9C43-1C152B4385E4Q60456283-3CA51570-289F-4919-9EB4-3B15598000F9Q91253144-B7F21D95-74C4-43ED-8783-E1780D9EF25BQ92519642-5146B2A0-0640-4F33-976B-7EEE6420CEE1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Claudia De Vitis
@en
Claudia De Vitis
@nl
type
label
Claudia De Vitis
@en
Claudia De Vitis
@nl
prefLabel
Claudia De Vitis
@en
Claudia De Vitis
@nl
P31
P496
0000-0001-8899-2347